Lv51
1380 积分 2024-03-31 加入
Flowchart for endometrial cancer classification integrating FIGO 2023 staging and ESGO/ESTRO/ESP 2025 risk categories
27分钟前
待确认
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
46分钟前
已完结
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance
1个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
1个月前
已完结
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes
1个月前
已完结
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes
1个月前
已完结
The prognostic value of p53 abnormal expression in non-myoinvasive endometrial cancer: a retrospective comparative study according to p53 status and myometrial invasion
3个月前
已关闭
Homologous recombination deficiency in endometrial cancer: shedding light on recent clinical findings
4个月前
已完结
POLE-mutated endometrial carcinoma with extreme morphological and molecular heterogeneity: spatial clonal divergence in a multiple-classifier tumor
6个月前
已完结
Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features
6个月前
已完结
皖公网安备34019202002308
